Publication | Closed Access

Tetraiodothyroacetic acid and transthyretin silencing inhibit pro-metastatic effect of L-thyroxin in anoikis-resistant prostate cancer cells through regulation of MAPK/ERK pathway

Mapk/erk PathwayUrologyTetraiodothyroacetic AcidInhibit Pro-metastatic EffectThyroid HormoneProstatic DiseaseMedicineRadiation OncologyTumor BiologyEndocrine-related Cancer